story of the week
Ocrelizumab in Patients With Progressive MS and a High Disability Level
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ocrelizumab in highly disabled progressive multiple sclerosis patients
Mult Scler Relat Disord 2024 Feb 01;82(xx)105345, M Houtchens, D HowardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.